For US Healthcare Professionals Only
Prescribe Altreno, the first and only acne treatment that provides the proven efficacy of tretinoin in a hydrating lotion.1,2
Model shown is for illustrative purposes only.
An expert panel of dermatologists and editors reviewed hundreds of skincare products, and Altreno was a winner!
See Mean Reduction Data (%)
*Treatment success was defined as at least a 2-grade improvement from baseline and an Evaluator’s Global Severity Score of clear (0) or almost clear (1). 2
Results of 2 phase 3, multicenter, randomized, double-blind, vehicle-controlled, parallel-group studies comparing the efficacy and safety of Altreno Lotion once daily for 12 weeks with vehicle in patients 9 years and older with moderate-to-severe acne vulgaris (baseline 20 to 40 inflammatory lesions). 1,2
*Treatment success was defined as at least a 2-grade improvement from baseline and an Evaluator’s Global Severity of clear (0) or almost clear (1). 2
Results of a phase 3, multicenter, randomized, double-blind, vehicle-controlled, parallel-group study comparing the efficacy and safety of Altreno lotion once daily for 12 weeks with vehicle in patients 9 years and older with moderate-to-severe acne vulgaris (baseline 20 to 100 comedonal lesions). 1,2
Baseline
Week 12
Photos have not been retouched. Individual results may vary.
For greater comfort, the lotion has been enriched with ingredients proven to hydrate the skin2-5 such as soluble collagen, glycerin and sodium hyaluronate (which is the sodium salt of hyaluronic acid and is valued as an excellent hydrating ingredient in topical skin care products3).
See what they said
In a customer perception study of 15 women, 86% of them agreed.
Results from a customer perception study of patients using only the lotion vehicle. In this self-assessment, 15 women, aged 35-65, applied the vehicle lotion to the left side of their face, while leaving the other side untreated.
In a customer perception study of 15 women, 80% of them agreed.
Clinical trials reported low incidence of adverse reactions to Altreno Lotion.
View the tolerability data
Results from a perception survey of healthcare professionals who tried the lotion vehicle. A total of 349 prescribers with practices in the U.S.A. tried the Altreno lotion vehicle and completed the survey.7
Need to start an account? Set up an account and place your order by calling 877-520-0500.
Already have an existing account? Place your order at aesthetics.mckesson.com or by calling 877-520-0500.
WAC $50 / Minimum order 12 units
WAC $115 / Minimum order 12 units
*Not all U.S states allow physicians to dispense prescription products from their offices.
Additional restrictions may apply. NY, TX, MT, NH, MA do not allow office-dispense.
**Valid until December 31 2020.
Medvantx helps simplify the traditional pharmacy experience by delivering prescriptions directly to the homes of your patients*
* No insurance benefits, including private insurance, Medicaid, Medicare, Tricare or any other federal or state healthcare programs (including any state prescription drug assistance programs) and the Government Health Insurance Plan available in Puerto Rico, can be used in conjunction with this program.
Medvantx documents Patient brochure
for Altreno Lotion and submit it to Medvantx.
and charges $115 to the patient's credit card, then delivers your patient’s prescription with free shipping.
of choice takes approximately 2 to 3 business days once the order is processed.
References
This website is intended for us healthcare professionals only.
Enter healthcare professional site Go to patient site
INDICATIONS AND USAGE Altreno (tretinoin) Lotion, 0.05% is indicated for the topical treatment of acne vulgaris in patients 9 years of age and older.
IMPORTANT SAFETY INFORMATION Altreno is for topical use only. Not for ophthalmic, oral, or intravaginal use.
Skin Irritation: Patients using Altreno may experience application site dryness, pain, erythema, irritation, and exfoliation. Depending upon the severity of these adverse reactions, instruct patients to use a moisturizer, reduce the frequency of the application of Altreno, or discontinue use. Avoid application of Altreno to eczematous or sunburned skin.
Ultraviolet Light and Environmental Exposure: Minimize unprotected exposure to ultraviolet light, including sunlight and sunlamps. Warn patients with frequent sun exposure and those with inherent sensitivity to sunlight to exercise caution. Use sunscreen and protective clothing over treated areas when exposure cannot be avoided.
Fish Allergies: Altreno contains soluble fish proteins. Use with caution in patients with known sensitivity or allergy to fish. Advise patients to contact their healthcare provider if they develop pruritus or urticaria.
Adverse Reactions: The most common adverse reactions in clinical trials were application site dryness (4%), pain (3%), erythema (2%), irritation (1%) and exfoliation (1%).
Nursing Women: It is not known whether topical administration of tretinoin could result in sufficient systemic absorption to produce detectable concentrations in human milk. The developmental health benefits of breastfeeding should be considered along with the mother’s clinical need for Altreno and any potential adverse effects on the breastfed child from Altreno.
To report suspected adverse reactions, contact Customer Service at 1-800-321-4576 or the FDA at 1-800-FDA-1088 or fda.gov/medwatch.
Please click here for full Prescribing Information.
Important safety information Altreno is for topical use only. Not for ophthalmic, oral, or intravaginal use.